Burn wounds are often complicated by bacterial infection, contributing to morbidity and mortality. Agents commonly used to treat burn wound infection are limited by toxicity, incomplete microbial coverage, inadequate penetration, and rising resistance. Curcumin is a naturally derived substance with innate antimicrobial and wound healing properties. Acting by multiple mechanisms, curcumin is less likely than current antibiotics to select for resistant bacteria. Curcumin's poor aqueous solubility and rapid degradation profile hinder usage; nanoparticle encapsulation overcomes this pitfall and enables extended topical delivery of curcumin. In this study, we synthesized and characterized curcumin nanoparticles (curc-np), which inhibited in vitro growth of methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa in dose-dependent fashion, and inhibited MRSA growth and enhanced wound healing in an in vivo murine wound model. Curc-np may represent a novel topical antimicrobial and wound healing adjuvant for infected burn wounds and other cutaneous injuries.

A novel room-temperature molten salt electrolyte based on urea and lithium bis(trifluoromethane sulfone)imide (LiN(SO2CF3)2, LiTFSI) has been synthesized and characterized by differential scanning calorimetry (DSC), Raman spectroscopy, ac impedance, and cyclic voltammetry. This electrolyte appears as a liquid at room temperature, though it is composed of two solids. DSC shows that its eutectic temperature is about −37.60 °C. Strong interactions between the two components observed by Raman spectroscopy weaken the bonding between the anions and the cations of LiTFSI, leading to the formation of a eutectic molten salt. The conduction behavior and the electrochemical window of this electrolyte have been evaluated by ac impedance spectroscopy and cyclic voltammetry, respectively.

Wound healing is a complex process driven largely by the migration of a variety of distinct cell types from the wound margin into the wound zone. In this study, we identify the previously uncharacterized microtubule-severing enzyme, Fidgetin-like 2 (FL2), as a fundamental regulator of cell migration that can be targeted in vivo using nanoparticle-encapsulated siRNA to promote wound closure and regeneration. In vitro, depletion of FL2 from mammalian tissue culture cells results in a more than two-fold increase in the rate of cell movement, due in part to a significant increase in directional motility. Immunofluorescence analyses indicate that FL2 normally localizes to the cell edge, importantly to the leading edge of polarized cells, where it regulates the organization and dynamics of the microtubule cytoskeleton. To clinically translate these findings, we utilized a nanoparticle-based siRNA delivery platform to locally deplete FL2 in both murine full-thickness excisional and burn wounds. Topical application of FL2 siRNA nanoparticles to either wound type results in a significant enhancement in the rate and quality of wound closure both clinically and histologically relative to controls. Taken together, these results identify FL2 as a promising therapeutic target to promote the regeneration and repair of cutaneous wounds.

No abstract

Cobalt oxide (Co(3)O(4)) nanopolyhedrons and nanosheets were controlled synthesized at the low temperature of 80 degrees C via a novel, simple, aqueous method; the obtained nanosheets are only 2-3 nm thick.

Lithiated Nafion 112 ionomer was characterized by FT-IR spectroscopy, AC impedance, and cyclic voltammetry. The ionomer swollen with mixed solvents of propylene carbonate (PC) and ethylene carbonate shows ionic conductivity of 8.18 · 10 )5 S cm )1 at 25°C and good electrochemical stability to allow operation in Li/ionomer/ LiCoO 2 cells. The discharge capacity of the first cycle is 126 mAh g )1 . Significant capacity loss occurs during cycling due to the presence of PC. AC impedance shows that the passive layer formed at the Li/ionomer interface dominates the cycling performance of the cell.

No abstract

In search of redox mechanisms in breast cancer, we uncovered a striking role for glutathione peroxidase 2 (GPx2) in oncogenic signaling and patient survival. GPx2 loss stimulates malignant progression due to reactive oxygen species/hypoxia inducible factor-α (HIF1α)/VEGFA (vascular endothelial growth factor A) signaling, causing poor perfusion and hypoxia, which were reversed by GPx2 reexpression or HIF1α inhibition. Ingenuity Pathway Analysis revealed a link between GPx2 loss, tumor angiogenesis, metabolic modulation, and HIF1α signaling. Single-cell RNA analysis and bioenergetic profiling revealed that GPx2 loss stimulated the Warburg effect in most tumor cell subpopulations, except for one cluster, which was capable of oxidative phosphorylation and glycolysis, as confirmed by coexpression of phosphorylated-AMPK and GLUT1. These findings underscore a unique role for redox signaling by GPx2 dysregulation in breast cancer, underlying tumor heterogeneity, leading to metabolic plasticity and malignant progression.